EU signs supply deal with J&J on potential Covid-19 vaccine

Johnson & Johnson

EU signs supply deal with J&J on potential COVID-19 vaccine

BRUSSELS (Reuters) – The European Commission said on Wednesday it had signed a contract on behalf of EU states with U.S. drugmaker Johnson & Johnson for the supply of 400 million doses of its COVID-19 vaccine candidate.

The move follows an advance purchase agreement signed by Brussels with Johnson & Johnson earlier in October.

 

Reporting by Francesco Guarascio @fraguarascio; Editing by John Chalmers

Our Standards: The Thomson Reuters Trust Principles.

 

Reuters source:

https://www.reuters.com/article/us-health-coronavirus-eu-j-j/eu-signs-supply-deal-with-jj-on-potential-covid-19-vaccine-idUSKBN2761AT